Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | ||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ||||
Dermatitis contact | Dermatitis contact | x | x | x | x | x | ||
Hypersensitivity | Hypersensitivity | x | x | x | ||||
Erythema | Erythema | x | x | |||||
Dermatitis atopic | Cutaneous hypersensitivity | x | x | |||||
Pain | Stinging | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |